T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EARN
2551
Ellington Residential Mortgage REIT
EARN
$166M
| $304K | ﹤0.01% |
24,666
-46
| -0.2% | -$569 |
|
2552
OrthoPediatrics
KIDS
$648M
| $299K | ﹤0.01% |
6,143
-11
| -0.2% | -$528 |
|
|
HMHC
2553
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $299K | ﹤0.01% |
39,253
-9,275
| -19% | -$53K |
|
2554
Andersons Inc
ANDE
$2.22B
| $298K | ﹤0.01% |
10,887
+1,567
| +17% | +$41.5K |
|
|
RJET
2555
Republic Airways Holdings
RJET
$967M
| $298K | ﹤0.01% |
1,478
+772
| +109% | +$121K |
|
|
SLCA
2556
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $298K | ﹤0.01% |
24,260
-11,096
| -31% | -$121K |
|
|
DBD
2557
DELISTED
Diebold Nixdorf Incorporated
DBD
| $298K | ﹤0.01% |
21,105
+2,650
| +14% | +$36.5K |
|
2558
Asure Software
ASUR
$240M
| $297K | ﹤0.01% |
38,930
+1,883
| +5% | +$15.1K |
|
|
HARP
2559
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $295K | ﹤0.01% |
1,408
+12
| +0.9% | +$2.4K |
|
2560
GoodRx Holdings
GDRX
$1.24B
| $293K | ﹤0.01% |
+7,500
| New | +$337K |
|
2561
KALA BIO
KALA
$17.2M
| $292K | ﹤0.01% |
17
+3
| +21% | +$58.6K |
|
2562
Rafael Holdings
RFL
$107M
| $292K | ﹤0.01% |
+7,409
| New | +$240K |
|
2563
Carriage Services
CSV
$550M
| $291K | ﹤0.01% |
8,283
+18
| +0.2% | +$625 |
|
|
BZUN
2564
Baozun
BZUN
$167M
| $290K | ﹤0.01% |
7,600
| – | – |
|
|
AIXC
2565
AIxCrypto Holdings Inc
AIXC
$14.9M
| $290K | ﹤0.01% |
+215
| New | +$364K |
|
|
FINV
2566
FinVolution Group
FINV
$1.07B
| $289K | ﹤0.01% |
+41,179
| New | +$219K |
|
2567
Cars.com
CARS
$653M
| $288K | ﹤0.01% |
22,186
-72
| -0.3% | -$944 |
|
2568
iBio
IBIO
$69.5M
| $287K | ﹤0.01% |
373
-73
| -16% | -$63.6K |
|
2569
Krystal Biotech
KRYS
$9.81B
| $287K | ﹤0.01% |
+3,719
| New | +$270K |
|
2570
World Acceptance Corp
WRLD
$896M
| $286K | ﹤0.01% |
2,201
-1,693
| -43% | -$223K |
|
|
FRG
2571
DELISTED
Franchise Group, Inc.
FRG
| $286K | ﹤0.01% |
7,908
+16
| +0.2% | +$567 |
|
2572
Artesian Resources
ARTNA
$368M
| $284K | ﹤0.01% |
7,204
-81
| -1% | -$3.16K |
|
|
RFP
2573
DELISTED
Resolute Forest Products Inc.
RFP
| $283K | ﹤0.01% |
25,800
-7,700
| -23% | -$68.3K |
|
2574
PAVmed
PAVM
$31.9M
| $282K | ﹤0.01% |
+141
| New | +$212K |
|
2575
Olema Pharmaceuticals
OLMA
$914M
| $280K | ﹤0.01% |
+8,450
| New | +$362K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.